← All stocks

Structure Therapeutics Inc.

GPCR No buying or selling

CIK 0001888886 #1593 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

8 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Yoon Jun

CHIEF FINANCIAL OFFICER

—

1,401,656

0.6552%

—

+24.8%

Stevens Raymond C

CHIEF EXECUTIVE OFFICER

—

1,401,593

0.6552%

—

+76.7%

Coll Crespo Blas

CHIEF MEDICAL OFFICER

—

280,878

0.1313%

—

+173.8%

Lin Xichen

CHIEF SCIENTIFIC OFFICER

—

228,960

0.1070%

—

+167.1%

Lang Matthew

COO & GC

—

184,614

0.0863%

—

Hall Ashley

Chief Development Officer

—

155,187

0.0725%

—

+130.6%

Berrios John Joseph

Chief Commercial Officer

—

140,766

0.0658%

—

Ma Yingli

CHIEF TECHNOLOGY OFFICER

—

139,917

0.0654%

—

+280.9%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Lin Xichen

1 Sep 2026

CHIEF SCIENTIFIC OFFICER

Exercised, kept

17,817

$0.34

$6.06K

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 35,634

History held since 6 Feb 2023